Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section
Status:
Completed
Trial end date:
2020-02-25
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the efficacy of Iv hyoscine butylbromide in preventing
Bradycardia during cesarean section under spinal anaesthesia with local anaesthetic and
morphine.